---
schema_version: "secwatch.filing_event.v1"
accession: "0000926326-23-000011"
form_type: "8-K"
ticker: "OMCL"
cik: "0000926326"
company_name: "OMNICELL, INC."
filed_at: "2023-05-02T23:59:59+00:00"
generated_at: "2026-06-16T04:27:58.763665+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Omnicell Q1 2023 revenue down 9% YoY to $291M, GAAP net loss of $0.33 per share

## Summary
- Total GAAP revenues $291M (-9% YoY); GAAP net loss $15M ($0.33 loss per share) vs net income $8M ($0.17) prior year.
- Non-GAAP net income $17M ($0.39 per share) vs $38M ($0.83) in Q1 2022; non-GAAP EBITDA $27M vs $50M.
- Cash and equivalents $340M; total debt $567M; operating cash flow $13M vs -$16M prior year.
- Full-year 2023 guidance unchanged: revenue $1.15B-$1.19B, non-GAAP EPS $1.55-$1.80 per share.
- Q2 2023 guidance: revenue $278M-$288M, non-GAAP EPS $0.25-$0.35.

## SEC filing metadata
- accession: 0000926326-23-000011
- form_type: 8-K
- ticker: OMCL
- cik: 0000926326
- company_name: OMNICELL, INC.
- filed_at: 2023-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926326/000092632623000011/0000926326-23-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926326/000092632623000011/omcl-20230502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926326-23-000011
- JSON: https://secwatch.observer/filing/0000926326-23-000011.json
- Plain text: https://secwatch.observer/filing/0000926326-23-000011.txt

## Key facts
- Earnings Releases
  OMNICELL, INC. reported the first quarter ended March 31, 2023 results: revenue $291 million, net income $15 million, EPS $0.33 per diluted share. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $291 million
  - Net income: $15 million
  - EPS: $0.33 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total GAAP revenues for the first quarter of 2023 were $291 million, down $28 million, or 9%, from the first quarter of 2022. The year-over-year decrease in total GAAP revenues reflects lower point-of-care revenues as a result of ongoing health systems capital budget constraints. Total GAAP net loss for the first quarter of 2023 was $15 million, or $0.33 per diluted share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926326/000092632623000011/0000926326-23-000011-index.htm
- Earnings Releases
  OMNICELL, INC. reported the full year 2023 results: revenue between $1.150 billion and $1.190 billion, EPS between $1.55 and $1.80 per share. Guidance reaffirmed.
  - Period: the full year 2023
  - Revenue: between $1.150 billion and $1.190 billion
  - EPS: between $1.55 and $1.80 per share
  - Guidance: reaffirmed
  - Result: guidance update
  source text: The Company’s full year 2023 guidance is unchanged. For the full year 2023, the Company expects bookings to be between $1.000 billion and $1.100 billion. The Company expects full year 2023 total revenues to be between $1.150 billion and $1.190 billion. The Company expects full year 2023 product revenues to be between $740 million and $760 million, and full year 2023 service revenues to be between $410 million and $430 million. The Company expects full year 2023 technical services revenues to be between $210 million and $220 million, and full year 2023 Advanced Services revenues to be between $200 million and $210 million. The Company expects full year 2023 non-GAAP EBITDA to be between $120 million and $135 million. The Company expects full year 2023 non-GAAP earnings per share to be between $1.55 and $1.80 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926326/000092632623000011/0000926326-23-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.